{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:38Z","timestamp":1790989058640,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C1003491"],"award-info":[{"award-number":["2022R1C1C1003491"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168445","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:22:11Z","timestamp":1788276131000},"page":"168445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rutaecarpine suppresses osteosarcoma progression and tumor-induced bone destruction by targeting the PRAS40-associated signaling network in an ex vivo metastasis model"],"prefix":"10.1016","volume":"1873","author":[{"given":"Hyung-Mun","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ran","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168445_bb0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168445_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12938-021-00860-0","article-title":"Osteosarcoma: a review of current and future therapeutic approaches","volume":"20","author":"Zhao","year":"2021","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.bbadis.2026.168445_bb0015","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment - where do we stand? A state of the art review","volume":"40","author":"Luetke","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"2023","key":"10.1016\/j.bbadis.2026.168445_bb0025","article-title":"Targeting signaling pathways in osteosarcoma: mechanisms and clinical studies","volume":"4","author":"Ji","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bbadis.2026.168445_bb0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbadis.2026.168445_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10295-015-1723-5","article-title":"Natural product discovery: past, present, and future","volume":"43","author":"Katz","year":"2016","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1199799","article-title":"Promising derivatives of rutaecarpine with diverse pharmacological activities","volume":"11","author":"Li","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbadis.2026.168445_bb0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.phrs.2018.12.019","article-title":"Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)","volume":"141","author":"Tian","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s000110050512","article-title":"A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa","volume":"48","author":"Moon","year":"1999","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0055","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0060","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1007\/s11999-009-0814-x","article-title":"Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study","volume":"467","author":"Urakawa","year":"2009","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.pai.0000213131.63417.fa","article-title":"Expression of cyclooxygenase-2 in osteosarcoma of bone","volume":"15","author":"Masi","year":"2007","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12967-023-04396-w","article-title":"Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase","volume":"21","author":"Lei","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168445_bb0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/acs.jnatprod.2c00224","article-title":"Antitumor activity of Rutaecarpine in human colorectal Cancer cells by suppression of Wnt\/beta-catenin signaling","volume":"85","author":"Byun","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbadis.2026.168445_bb0080","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/onc.2014.91","article-title":"Nuclear PRAS40 couples the Akt\/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway","volume":"34","author":"Havel","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168445_bb0085","doi-asserted-by":"crossref","first-page":"E1453","DOI":"10.1152\/ajpendo.00660.2011","article-title":"Role of PRAS40 in Akt and mTOR signaling in health and disease","volume":"302","author":"Wiza","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2026.168445_bb0090","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.drudis.2016.04.005","article-title":"Targeting PRAS40 for multiple diseases","volume":"21","author":"Chong","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbadis.2026.168445_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114753","article-title":"ST1936 stimulates osteoclastogenesis and suppresses osteoclastic apoptosis through the ERK1\/2 signaling pathway in bone marrow-derived macrophages","volume":"157","author":"Yun","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.70187","article-title":"Saucerneol inhibits the growth, migration, and invasion of osteosarcoma cells in vitro and prevents metastasis-associated Osteolysis ex vivo","volume":"69","author":"Yun","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0105","article-title":"Effect of Spicatoside a on anti-osteosarcoma MG63 cells through reactive oxygen species generation and the inhibition of the PI3K-AKT-mTOR pathway","volume":"13","author":"Yun","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bbadis.2026.168445_bb0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7150\/ijbs.37781","article-title":"G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway","volume":"16","author":"Park","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2026.168445_bb0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2010.02.002","article-title":"Phosphorylation of PRAS40 on Thr246 by PKB\/AKT facilitates efficient phosphorylation of Ser183 by mTORC1","volume":"22","author":"Nascimento","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2026.168445_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168445_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168445_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.118635","article-title":"Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer","volume":"1867","author":"Evangelisti","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2026.168445_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fonc.2020.00402","article-title":"Prognostic significance of beta-catenin expression in osteosarcoma: a Meta-analysis","volume":"10","author":"Xie","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0145","doi-asserted-by":"crossref","first-page":"17570","DOI":"10.18632\/oncotarget.4100","article-title":"Aberrant activation of Wnt\/beta-catenin signaling drives proliferation of bone sarcoma cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2026.168445_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168445_bb0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2026.168445_bb0160","doi-asserted-by":"crossref","first-page":"930","DOI":"10.21037\/atm-22-3765","article-title":"Rutaecarpine prevents the malignant biological properties of breast cancer cells by the miR-149-3p\/S100A4 axis","volume":"10","author":"Xiong","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bbadis.2026.168445_bb0165","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2026.168445_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander Haar","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168445_bb0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/pin.13080","article-title":"Translational cell biology of highly malignant osteosarcoma","volume":"71","author":"Roessner","year":"2021","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbadis.2026.168445_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jss.2004.12.016","article-title":"Matrix metalloproteinases participate in osteosarcoma invasion","volume":"127","author":"Bjornland","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbadis.2026.168445_bb0185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/mt.2011.53","article-title":"MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression","volume":"19","author":"Osaki","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2026.168445_bb0190","doi-asserted-by":"crossref","first-page":"16588","DOI":"10.3390\/molecules191016588","article-title":"Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2\/\u22129 in vitro","volume":"19","author":"Shang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2026.168445_bb0195","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1073\/pnas.72.11.4435","article-title":"Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro","volume":"72","author":"Shin","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2026.168445_bb0200","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41419-021-03890-7","article-title":"Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis","volume":"12","author":"Deng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168445_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600311X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392600311X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:37Z","timestamp":1790987137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392600311X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S092544392600311X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168445","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rutaecarpine suppresses osteosarcoma progression and tumor-induced bone destruction by targeting the PRAS40-associated signaling network in an ex vivo metastasis model","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168445"}}